Annual Total Expenses
$65.69 M
-$24.06 M-26.81%
31 December 2023
Summary:
Aquestive Therapeutics annual total expenses is currently $65.69 million, with the most recent change of -$24.06 million (-26.81%) on 31 December 2023. During the last 3 years, it has fallen by -$19.83 million (-23.19%). AQST annual total expenses is now -43.55% below its all-time high of $116.37 million, reached on 31 December 2018.AQST Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$21.83 M
+$1.79 M+8.92%
30 September 2024
Summary:
Aquestive Therapeutics quarterly total expenses is currently $21.83 million, with the most recent change of +$1.79 million (+8.92%) on 30 September 2024. Over the past year, it has increased by +$4.71 million (+27.55%). AQST quarterly total expenses is now -53.19% below its all-time high of $46.63 million, reached on 30 June 2018.AQST Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AQST Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +27.6% |
| 3 y3 years | -23.2% | -4.0% |
| 5 y5 years | -37.6% | -17.1% |
AQST Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.8% | at low | -16.1% | +42.0% |
| 5 y | 5 years | -37.6% | at low | -17.1% | +42.0% |
| alltime | all time | -43.5% | +24.8% | -53.2% | +43.6% |
Aquestive Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.83 M(+8.9%) |
| June 2024 | - | $20.04 M(-4.6%) |
| Mar 2024 | - | $21.01 M(+22.7%) |
| Dec 2023 | $65.69 M(-26.8%) | $17.12 M(+11.3%) |
| Sept 2023 | - | $15.38 M(-11.9%) |
| June 2023 | - | $17.45 M(+10.9%) |
| Mar 2023 | - | $15.74 M(-26.4%) |
| Dec 2022 | $89.75 M(+5.0%) | $21.39 M(+5.3%) |
| Sept 2022 | - | $20.32 M(-21.9%) |
| June 2022 | - | $26.03 M(+18.3%) |
| Mar 2022 | - | $22.01 M(-3.2%) |
| Dec 2021 | $85.51 M(-3.6%) | $22.75 M(+7.0%) |
| Sept 2021 | - | $21.25 M(-2.8%) |
| June 2021 | - | $21.86 M(+11.3%) |
| Mar 2021 | - | $19.65 M(-13.8%) |
| Dec 2020 | $88.74 M | $22.80 M(+3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $22.04 M(+3.6%) |
| June 2020 | - | $21.28 M(-5.9%) |
| Mar 2020 | - | $22.63 M(-14.0%) |
| Dec 2019 | $105.28 M(-9.5%) | $26.32 M(+12.4%) |
| Sept 2019 | - | $23.42 M(-21.5%) |
| June 2019 | - | $29.82 M(+15.9%) |
| Mar 2019 | - | $25.72 M(-11.9%) |
| Dec 2018 | $116.37 M(+73.6%) | $29.18 M(+29.9%) |
| Sept 2018 | - | $22.47 M(-51.8%) |
| June 2018 | - | $46.63 M(+157.6%) |
| Mar 2018 | - | $18.11 M(-6.9%) |
| Dec 2017 | $67.03 M(+27.4%) | $19.45 M(+16.3%) |
| Sept 2017 | - | $16.73 M(+10.0%) |
| June 2017 | - | $15.20 M(-2.9%) |
| Mar 2017 | - | $15.65 M |
| Dec 2016 | $52.63 M | - |
FAQ
- What is Aquestive Therapeutics annual total expenses?
- What is the all time high annual total expenses for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly total expenses year-on-year change?
What is Aquestive Therapeutics annual total expenses?
The current annual total expenses of AQST is $65.69 M
What is the all time high annual total expenses for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual total expenses is $116.37 M
What is Aquestive Therapeutics quarterly total expenses?
The current quarterly total expenses of AQST is $21.83 M
What is the all time high quarterly total expenses for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly total expenses is $46.63 M
What is Aquestive Therapeutics quarterly total expenses year-on-year change?
Over the past year, AQST quarterly total expenses has changed by +$4.71 M (+27.55%)